Pennsylvania
Prescription drug spending and prescribing in Pennsylvania, from Medicare Part D and Medicaid, with the life-science companies raising money there and state attorney general health-care antitrust cases. Compare every state.
In 2024, Medicare Part D plans paid $14.0B for prescriptions written in Pennsylvania, the 5th most of 52 states and territories, and 2.9% of its claims were opioids against 3.5% nationally.
- Medicare Part D, 2024: $14.0B
- Medicaid drugs, 2025: $5.4B
- Opioid share of claims: 2.9%
- Life-science raises, 2 years: $771M
How It Prescribes
Medicare Part D, 2024, by the prescriber's state| Share of Part D claims | Pennsylvania | United States | Difference |
|---|---|---|---|
| Opioids | 2.9% | 3.5% | -17% |
| Antibiotics | 4.2% | 4.4% | -5% |
| Antipsychotics | 1.8% | 1.7% | +5% |
Most Distinctive Drugs
Prescribed most out of line with the rest of the country: the drug's share of Pennsylvania's claims against its share nationally| Drug | Against national rate | Claims |
|---|---|---|
| Repaglinide | 3.1× | 55,043 |
| Cefuroxime Axetil | 1.7× | 93,894 |
| Umeclidinium Brm/Vilanterol Tr | 1.6× | 110,644 |
| Bumetanide | 1.6× | 189,347 |
| Dofetilide | 1.6× | 25,488 |
| Lorazepam | 1.5× | 594,639 |
| Linagliptin | 1.5× | 104,695 |
| Fluticasone/Vilanterol | 1.5× | 198,682 |
| Pen Needle,dual Safety,diabetc | 1.5× | 27,049 |
| Nadolol | 1.4× | 18,542 |
Biggest Medicaid Drugs
What Pennsylvania's Medicaid program paid pharmacies, before rebates; see every drugLife-Science Fundraising
118 Form D raises by companies based in Pennsylvania in the last two years; the 10 largest. See all raises- Aclaris Therapeutics, Inc.$80M · Pharma · Dec 4, 2024
- Castle Creek Biosciences, Inc.$75M · Biotech · Feb 25, 2025
- FORE US Bio Inc.$70M · Biotech · May 15, 2025
- Belong Health, Inc.$57M · Other health care · Jul 11, 2025
- Alveus Therapeutics, Inc.$57M · Pharma · Jan 14, 2026
- Verrica Pharmaceuticals Inc.$50M · Pharma · Dec 10, 2025
- Verismo Therapeutics, Inc.$28M · Other health care · May 20, 2026
- Daymark Health, Inc.$26M · Other health care · Sep 3, 2025
- Cagent Vascular, Inc.$24M · Other health care · Jun 5, 2026
- Lungpacer Medical, Inc.$16M · Other health care · Apr 28, 2026
State Attorney General Health-Care Cases
Antitrust cases Pennsylvania joined, newest first; see every case- Connecticut, et al. v. Sandoz, et al., Case No. 20-cv-3539 (E.D. Pa. June 10, 2020), MDL 2724 (E.D. Pa.)2020 · Pending
- FTC et al. v. Vyera Pharmaceuticals, No. 1:20-cv-00706 (S.D.N.Y. Apr. 19, 2020)2020 · Final judgment
- Connecticut et al. v. Teva Pharmaceuticals USA, Inc. et al., No. 2:19-cv-02407, (E.D. Pa. filed in MDL 05/30/2019)2019 · Pending
- State of Wisconsin et al. v. Indivior, No. 16-5073 (E.D. Pa. Sept. 22,2016)2016 · Pending
- Connecticut et al. v. Teva Pharmaceuticals et al. Civ. Action No. (D.Conn. Dec. 15, 2016)2016 · Pending
- New York et al. v. Cephalon, No. 2:16-cv-04234 (E.D. Pa. Aug. 4, 2016)2016 · Settled
- FTC and Pennsylvania v. Penn State Hershey Medical Center, 838 F.3d 327 (3d Cir. 2016)2016 · Injunction granted
- Commonwealth of Pennsylvania v. Geisinger Health System Foundation et al., No. 1:13-cv-02647 (M.D. Pa. Oct. 25, 2013)2013 · Settled
- Pennsylvania v. Geisinger Medical Center, No. 344 MD 2011 (Pa. Comm. Ct. July 26, 2011)2011 · Settled
- Florida et al. v. Abbott Laboratories et al., No. 1:08-cv-00155-SLR (D.Del. 2007)2007 · Settled
Other States
Alabama · Alaska · Arizona · Arkansas · California · Colorado · Connecticut · Delaware · District of Columbia · Florida · Georgia · Hawaii · Idaho · Illinois · Indiana · Iowa · Kansas · Kentucky · Louisiana · Maine · Maryland · Massachusetts · Michigan · Minnesota · Mississippi · Missouri · Montana · Nebraska · Nevada · New Hampshire · New Jersey · New Mexico · New York · North Carolina · North Dakota · Ohio · Oklahoma · Oregon · Puerto Rico · Rhode Island · South Carolina · South Dakota · Tennessee · Texas · Utah · Vermont · Virginia · Washington · West Virginia · Wisconsin · Wyoming
Part D is by the prescriber's state, Medicaid by the paying state program, and Form D by the issuer's stated address. Amounts are before manufacturer rebates. Refreshed weekly. CMS Medicare Part D Prescribers by Geography; CMS State Drug Utilization Data; SEC Form D; NAAG